A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin

NCT01540487 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

NCT07333742 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets

NCT02821910 ·Status: COMPLETED ·Phase: PHASE1

Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes

NCT05440591 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

NCT02637037 ·Status: COMPLETED ·Phase: PHASE1

The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions

NCT03216278 ·Status: COMPLETED ·Phase: PHASE1

To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately

NCT01535677 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

NCT00798161 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

NCT01422876 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers

NCT02167061 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs

NCT03787017 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.

NCT01443221 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

NCT01376557 ·Status: COMPLETED ·Phase: PHASE2

A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components

NCT01780051 ·Status: COMPLETED ·Phase: PHASE1

Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027)

NCT00944450 ·Status: COMPLETED ·Phase: PHASE1

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

NCT01055691 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years

NCT07216131 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers

NCT02221401 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg

NCT03787043 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.

NCT04856007 ·Status: COMPLETED ·Phase: PHASE1

A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

NCT02088918 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets

NCT01845077 ·Status: COMPLETED ·Phase: PHASE1

Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes

NCT01512979 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants

NCT03467945 ·Status: COMPLETED ·Phase: PHASE1

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

NCT03593707 ·Status: COMPLETED ·Phase: PHASE1